ABOUT THIS MEDICATION
HUMULIN has been produced by recombinant DNA processes. It differs from animal-source insulins because it is structurally identical to the insulin produced by your body’s pancreas and
because of its unique manufacturing process.
HUMULIN 30/70 is a fixed mixture of 30% HUMULIN RRegular (insulin injection, human biosynthetic) and 70% HUMULIN N- NPH (insulin isophane, human biosynthetic). It is an intermediate-acting insulin with a more rapid onset of action than NPH insulin alone. The duration of activity may last up to 24 hours following injection.
HUMULIN 30/70 cartridges are for subcutaneous (under the skin) injection only.
What the medication is used for:
HUMULIN 30/70 is a combination of an intermediate-acting and a short-acting insulin used to treat patients diagnosed with diabetes mellitus.
What it does:
Insulin is a hormone that decreases the amount of sugar in your blood and urine by increasing the uptake of sugar from your blood into various tissues, such as the liver, muscles, and fat.
To control your diabetes, your doctor has prescribed injections of insulin to keep your blood sugar at a nearly normal level and to keep your urine as free of sugar as possible.
When it should not be used:
HUMULIN 30/70 should not be used if you are allergic to this drug or any of the ingredients used to formulate this medication.
HUMULIN 30/70 should not be used during episodes of hypoglycemia (low blood sugar).
HUMULIN 30/70 should not be given intravenously or used for treatment of diabetic coma.
There are no reviews yet.